This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.
Study Type
OBSERVATIONAL
Enrollment
6
Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels.
Asan Medical Center
Seoul, South Korea
a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
Time frame: 5 years
All death
Time frame: 5 years
Cardiac death
Time frame: 5 years
Myocardial infarction
Time frame: 5 years
a composite event of all death or myocardial infarction
Time frame: 5 years
a composite event of cardiac death or myocardial infarction
Time frame: 5 years
TVR(Target Vessel Revascularization)
Time frame: 5 years
TLR(Target Lesion Revascularization)
Time frame: 5 years
Stent thrombosis
by an Academic Research Consortium (ARC) category
Time frame: 5 years
Cerebrovascular event
Time frame: 5 years
Procedural success
Procedural success is defined as \< 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 5 days